Rafick P. Sekaly - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Microbiology Biology

143 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Aid M, Dupuy FP, Moysi E, Moir S, Haddad EK, Estes JD, Sekaly RP, Petrovas C, Ribeiro SP. Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective. Frontiers in Immunology. 9: 895. PMID 29967602 DOI: 10.3389/fimmu.2018.00895  0.32
2016 Liu J, Haddad EK, Marceau J, Morabito KM, Rao SS, Filali-Mouhim A, Sekaly RP, Graham BS. A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology. Plos Pathogens. 12: e1005486. PMID 26943673 DOI: 10.1371/journal.ppat.1005486  0.32
2015 Cleret-Buhot A, Zhang Y, Planas D, Goulet JP, Monteiro P, Gosselin A, Wacleche VS, Tremblay CL, Jenabian MA, Routy JP, El-Far M, Chomont N, Haddad EK, Sekaly RP, Ancuta P. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology. 12: 102. PMID 26654242 DOI: 10.1186/s12977-015-0226-9  0.88
2015 Alter G, Sekaly RP. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity. Vaccine. 33: B55-9. PMID 26022570 DOI: 10.1016/j.vaccine.2015.03.058  0.88
2015 Roychoudhuri R, Lefebvre F, Honda M, Pan L, Ji Y, Klebanoff CA, Nichols CN, Fourati S, Hegazy AN, Goulet JP, Gattinoni L, Nabel GJ, Gilliet M, Cameron M, Restifo NP, et al. Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation. Vaccine. 33: 914-23. PMID 25446821 DOI: 10.1016/j.vaccine.2014.10.007  0.88
2014 Cockerham LR, Jain V, Sinclair E, Glidden DV, Hartogenesis W, Hatano H, Hunt PW, Martin JN, Pilcher CD, Sekaly R, McCune JM, Hecht FM, Deeks SG. Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease. Aids (London, England). 28: 1749-58. PMID 24871455 DOI: 10.1097/QAD.0000000000000314  0.88
2013 Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, He Z, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, ... ... Sekaly RP, et al. Correction: Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity. Plos Pathogens. 9. PMID 29294479 DOI: 10.1371/annotation/8fa70b21-32e7-4ed3-b397-ab776b5bbf30  0.32
2013 Phetsouphanh C, Xu Y, Amin J, Seddiki N, Procopio F, Sekaly RP, Zaunders JJ, Kelleher AD. Characterization of transcription factor phenotypes within antigen-specific CD4+ T cells using qualitative multiplex single-cell RT-PCR. Plos One. 8: e74946. PMID 24124462 DOI: 10.1371/journal.pone.0074946  0.88
2013 Lederman MM, Funderburg NT, Sekaly RP, Klatt NR, Hunt PW. Residual immune dysregulation syndrome in treated HIV infection. Advances in Immunology. 119: 51-83. PMID 23886064 DOI: 10.1016/B978-0-12-407707-2.00002-3  0.88
2013 Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, ... ... Sekaly RP, et al. Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. Plos Pathogens. 9: e1003298. PMID 23633948 DOI: 10.1371/journal.ppat.1003298  0.88
2013 Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, Richman DD, Sekaly RP. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 381: 2109-17. PMID 23541541 DOI: 10.1016/S0140-6736(13)60104-X  0.88
2013 Darlington PJ, Touil T, Doucet JS, Gaucher D, Zeidan J, Gauchat D, Corsini R, Kim HJ, Duddy M, Jalili F, Arbour N, Kebir H, Chen J, Arnold DL, Bowman M, ... ... Sekaly R, et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Annals of Neurology. 73: 341-54. PMID 23463494 DOI: 10.1002/ana.23784  0.88
2013 Tzelepis F, Joseph J, Haddad EK, Maclean S, Dudani R, Agenes F, Peng SL, Sekaly RP, Sad S. Intrinsic role of FoxO3a in the development of CD8+ T cell memory. Journal of Immunology (Baltimore, Md. : 1950). 190: 1066-75. PMID 23277488 DOI: 10.4049/jimmunol.1200639  0.88
2013 Costiniuk CT, Kovacs C, Routy JP, Singer J, Gurunathan S, Sekaly RP, Angel JB. Short communication: human immunodeficiency virus rebound in blood and seminal plasma following discontinuation of antiretroviral therapy. Aids Research and Human Retroviruses. 29: 266-9. PMID 22908887 DOI: 10.1089/AID.2011.0343  0.88
2012 Routy JP, Angel JB, Spaans JN, Trottier B, Rouleau D, Baril JG, Harris M, Trottier S, Singer J, Chomont N, Sékaly RP, Tremblay CL. Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir. Hiv Clinical Trials. 13: 301-7. PMID 23195668 DOI: 10.1310/hct1306-301  0.88
2012 Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen SI, Bae JY, Reyes MD, Swanson T, Legasse AW, Sylwester A, Hansen SG, Smith AT, et al. Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nature Medicine. 18: 1673-81. PMID 22961108 DOI: 10.1038/nm.2934  0.88
2012 van Grevenynghe J, Cubas RA, DaFonseca S, Metcalf T, Tremblay CL, Trautmann L, Sekaly RP, Schatzle J, Haddad EK. Foxo3a: an integrator of immune dysfunction during HIV infection. Cytokine & Growth Factor Reviews. 23: 215-21. PMID 22748238 DOI: 10.1016/j.cytogfr.2012.05.008  0.88
2012 Lévy Y, Sereti I, Tambussi G, Routy JP, Lelièvre JD, Delfraissy JF, Molina JM, Fischl M, Goujard C, Rodriguez B, Rouzioux C, Avettand-Fenoël V, Croughs T, Beq S, Morre M, ... ... Sekaly RP, et al. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 291-300. PMID 22550117 DOI: 10.1093/cid/cis383  0.88
2012 Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R, Pinyakorn S, Phanuphak N, Trichavaroj R, Rutvisuttinunt W, Chomchey N, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. Plos One. 7: e33948. PMID 22479485 DOI: 10.1371/journal.pone.0033948  0.88
2012 Songok EM, Luo M, Liang B, Mclaren P, Kaefer N, Apidi W, Boucher G, Kimani J, Wachihi C, Sekaly R, Fowke K, Ball BT, Plummer FA. Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. Plos One. 7: e30048. PMID 22291902 DOI: 10.1371/journal.pone.0030048  0.88
2012 Routy JP, Tremblay CL, Angel JB, Trottier B, Rouleau D, Baril JG, Harris M, Trottier S, Singer J, Chomont N, Sékaly RP, Boulassel MR. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. Hiv Medicine. 13: 291-6. PMID 22276680 DOI: 10.1111/j.1468-1293.2011.00975.x  0.88
2012 Wilkinson P, Filali-Mouhim A, Li S, Ahlers J, Schatzle J, Pulendran B, Sekaly RP, Cameron MJ. An open-ended plea for the development of a global database of HIV vaccine responses Current Opinion in Hiv and Aids. 7: 10-16. PMID 22156846 DOI: 10.1097/COH.0b013e32834e390a  0.88
2012 Mbitikon-Kobo FM, Bonneville M, Sekaly RP, Trautmann L. Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells. Journal of Immunological Methods. 375: 252-7. PMID 21996428 DOI: 10.1016/j.jim.2011.09.008  0.88
2011 Kibler KV, Gomez CE, Perdiguero B, Wong S, Huynh T, Holechek S, Arndt W, Jimenez V, Gonzalez-Sanz R, Denzler K, Haddad EK, Wagner R, Sékaly RP, Tartaglia J, Pantaleo G, et al. Improved NYVAC-based vaccine vectors. Plos One. 6: e25674. PMID 22096477 DOI: 10.1371/journal.pone.0025674  0.88
2011 Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet JP, Haddad EK, Breton G, Trumpfheller C, Pollak S, Shimeliovich I, Duque-Alarcon A, Pan L, Nelkenbaum A, Salazar AM, Schlesinger SJ, et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. The Journal of Experimental Medicine. 208: 2357-66. PMID 22065672 DOI: 10.1084/jem.20111171  0.88
2011 Trautmann L, Sekaly RP. Solving vaccine mysteries: A systems biology perspective Nature Immunology. 12: 729-731. PMID 21772284 DOI: 10.1038/ni.2078  0.88
2011 Malaspina A, Rinaldo CR, Sekaly RP, Flores J, D'Souza PM. "In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates", NIAID Workshop Report, Bethesda, August 4, 2010. Vaccine. 29: 4647-53. PMID 21571022 DOI: 10.1016/j.vaccine.2011.04.035  0.88
2011 Flatz L, Roychoudhuri R, Honda M, Filali-Mouhim A, Goulet JP, Kettaf N, Lin M, Roederer M, Haddad EK, Sékaly RP, Nabel GJ. Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines. Proceedings of the National Academy of Sciences of the United States of America. 108: 5724-9. PMID 21422297 DOI: 10.1073/pnas.1013084108  0.88
2011 Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet JP, Loof NM, Ossendorp F, Perdiguero B, Heinen P, Gomez CE, Kibler KV, Koelle DM, et al. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. Plos One. 6: e16819. PMID 21347234 DOI: 10.1371/journal.pone.0016819  0.88
2010 Ancuta P, Monteiro P, Sekaly RP. Th17 lineage commitment and HIV-1 pathogenesis. Current Opinion in Hiv and Aids. 5: 158-65. PMID 20543594 DOI: 10.1097/COH.0b013e3283364733  0.88
2010 Ndongala ML, Kamya P, Boulet S, Peretz Y, Rouleau D, Tremblay C, Leblanc R, Côté P, Baril JG, Thomas R, Vézina S, Boulassel MR, Routy JP, Sékaly RP, Bernard NF. Changes in function of HIV-specific T-cell responses with increasing time from infection. Viral Immunology. 23: 159-68. PMID 20373996 DOI: 10.1089/vim.2009.0084  0.88
2010 Saïdi H, Carbonneil C, Magri G, Eslahpazir J, Sekaly RP, Bélec L. Differential modulation of CCR5-tropic human immunodeficiency virus-1 transfer from macrophages towards T cells under interleukin-4/interleukin-13 microenvironment. Human Immunology. 71: 1-13. PMID 19706316 DOI: 10.1016/j.humimm.2009.08.011  0.88
2009 Horton RE, Kaefer N, Songok E, Guijon FB, Kettaf N, Boucher G, Sekaly RP, Ball TB, Plummer FA. A comparative analysis of gene expression patterns and cell phenotypes between cervical and peripheral blood mononuclear cells. Plos One. 4: e8293. PMID 20011545 DOI: 10.1371/journal.pone.0008293  0.88
2009 Oyugi JO, Vouriot FC, Alimonti J, Wayne S, Luo M, Land AM, Ao Z, Yao X, Sekaly RP, Elliott LJ, Simonsen JN, Ball TB, Jaoko W, Kimani J, Plummer FA, et al. A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers. The Journal of Infectious Diseases. 199: 1327-34. PMID 19301975 DOI: 10.1086/597616  0.88
2008 van Grevenynghe J, Halwani R, Chomont N, Ancuta P, Peretz Y, Tanel A, Procopio FA, shi Y, Said EA, Haddad EK, Sekaly RP. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection. Seminars in Immunology. 20: 196-203. PMID 18757210 DOI: 10.1016/j.smim.2008.07.008  0.32
2008 Mercier F, Boulassel MR, Yassine-Diab B, Tremblay C, Bernard NF, Sekaly RP, Routy JP. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Rα on central and effector memory CD4 + and CD8+ T cell subsets Clinical and Experimental Immunology. 152: 72-80. PMID 18279439 DOI: 10.1111/j.1365-2249.2008.03610.x  0.88
2008 Sekaly RP. The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development? Journal of Experimental Medicine. 205: 7-12. PMID 18195078 DOI: 10.1084/jem.20072681  0.88
2007 Wang C, Wen T, Routy JP, Bernard NF, Sekaly RP, Watts TH. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 8252-63. PMID 18056369  0.88
2007 Braun RK, Rudnicki MA, Sekaly RP, Filion LG. Filter selection for five color flow cytometric analysis with a single laser International Journal of Laboratory Hematology. 29: 369-376. PMID 17824918 DOI: 10.1111/j.1365-2257.2006.00852.x  0.88
2007 Peretz Y, Ndongala ML, Boulet S, Boulassel MR, Rouleau D, Côté P, Longpré D, Routy JP, Falutz J, Tremblay C, Tsoukas CM, Sékaly RP, Bernard NF. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression. Clinical Immunology (Orlando, Fla.). 124: 57-68. PMID 17521962 DOI: 10.1016/j.clim.2007.04.004  0.88
2007 Boulet S, Ndongala ML, Peretz Y, Boisvert MP, Boulassel MR, Tremblay C, Routy JP, Sekaly RP, Bernard NF. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. Journal of Immunological Methods. 320: 18-29. PMID 17222422 DOI: 10.1016/j.jim.2006.11.010  0.88
2007 Younes SA, Trautmann L, Yassine-Diab B, Kalfayan LH, Kernaleguen AE, Cameron TO, Boulassel R, Stern LJ, Routy JP, Grossman Z, Dumont AR, Sekaly RP. The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 788-97. PMID 17202340  0.88
2007 Dion ML, Bordi R, Zeidan J, Asaad R, Boulassel MR, Routy JP, Lederman MM, Sekaly RP, Cheynier R. Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection. Blood. 109: 2912-20. PMID 17164338 DOI: 10.1182/blood-2006-09-047308  0.88
2007 Trautmann L, Said EA, Halwani R, Janbazian L, Chomont N, El-Far M, Breton G, Haddad EK, Sekaly RP. Programmed death 1: A critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections Current Opinion in Hiv and Aids. 2: 219-227. DOI: 10.1097/COH.0b013e3280ebb5c9  0.88
2006 Riou C, Dumont AR, Yassine-Diab B, Haddad EK, Sekaly RP. IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells. International Immunology. 18: 827-35. PMID 16611649 DOI: 10.1093/intimm/dxl019  0.88
2005 Serghides L, Bukczynski J, Wen T, Wang C, Routy JP, Boulassel MR, Sekaly RP, Ostrowski M, Bernard NF, Watts TH. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. Journal of Immunology (Baltimore, Md. : 1950). 175: 6368-77. PMID 16272289  0.88
2005 Rose JJ, Janvier K, Chandrasekhar S, Sekaly RP, Bonifacino JS, Venkatesan S. CD4 down-regulation by HIV-1 and simian immunodeficiency virus (SIV) Nef proteins involves both internalization and intracellular retention mechanisms. The Journal of Biological Chemistry. 280: 7413-26. PMID 15611114 DOI: 10.1074/jbc.M409420200  0.88
2004 Routy JP, Machouf N, Edwardes MD, Brenner BG, Thomas R, Trottier B, Rouleau D, Tremblay CL, Côté P, Baril JG, Remis RS, Sékaly RP, Wainberg MA. Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal. Aids (London, England). 18: 2305-12. PMID 15577543 DOI: 10.1097/00002030-200411190-00011  0.88
2004 Boulassel MR, Young M, Routy JP, Sekaly RP, Tremblay C, Rouleau D. Circulating levels of IL-7 but not IL-15, IGF-1, and TGF-β are elevated during primary HIV-1 infection Hiv Clinical Trials. 5: 357-359. PMID 15562373 DOI: 10.1310/M0CV-R6BX-A9DP-JJV0  0.88
2004 Belshe R, Franchini G, Girard MP, Gotch F, Kaleebu P, Marthas ML, McChesney MB, McCullough R, Mhalu F, Salmon-Ceron D, Sekaly RP, van Rompay K, Verrier B, Wahren B, Weissenbacher M. Support for the RV144 HIV vaccine trial. Science (New York, N.Y.). 305: 177-80; author reply. PMID 15247455 DOI: 10.1126/science.305.5681.177b  0.88
2004 Aouad SM, Cohen LY, Sharif-Askari E, Haddad EK, Alam A, Sekaly RP. Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. Journal of Immunology (Baltimore, Md. : 1950). 172: 2316-23. PMID 14764700  0.88
2003 Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, Allen TM, Feeney ME, Kahn JO, Sekaly RP, Levy JA, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. Aids (London, England). 17: 2581-91. PMID 14685052 DOI: 10.1097/01.aids.0000096870.36052.b6  0.88
2003 Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, Sekaly RP. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. The Journal of Experimental Medicine. 198: 1909-22. PMID 14676302 DOI: 10.1084/jem.20031598  0.88
2003 Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, Wilson D, Ayyavoo V, Montaner LJ, Kieber-Emmons T, Sekaly RP, Weiner DB. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. Journal of Immunology (Baltimore, Md. : 1950). 171: 4311-9. PMID 14530356  0.88
2003 Khalil H, Brunet A, Saba I, Terra R, Sékaly RP, Thibodeau J. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. International Immunology. 15: 1249-63. PMID 13679394 DOI: 10.1093/intimm/dxg124  0.88
2003 Boulassel MR, Spurll G, Rouleau D, Tremblay C, Edwardes M, Sekaly RP, Lalonde R, Routy JP. Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis Journal of Clinical Apheresis. 18: 55-60. PMID 12874816 DOI: 10.1002/jca.10051  0.88
2003 Alter G, Hatzakis G, Tsoukas CM, Pelley K, Rouleau D, LeBlanc R, Baril JG, Dion H, Lefebvre E, Thomas R, Côté P, Lapointe N, Routy JP, Sékaly RP, Conway B, et al. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. Journal of Immunology (Baltimore, Md. : 1950). 171: 477-88. PMID 12817033 DOI: 10.4049/jimmunol.171.1.477  0.88
2003 Geenen V, Poulin JF, Dion ML, Martens H, Castermans E, I Hansenne, Moutschen M, Sékaly RP, Cheynier R. Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. The Journal of Endocrinology. 176: 305-11. PMID 12630915 DOI: 10.1677/joe.0.1760305  0.88
2003 Boyer JD, Kutzler MA, Chattergoon MA, Calarota SA, Pavlakis G, Sekaly RP, MacGregor RR, Weiner DB. Engineering DNA vaccination as an approach to HIV immune therapy Clinical and Applied Immunology Reviews. 3: 183-197. DOI: 10.1016/S1529-1049(02)00158-7  0.88
2002 Boyer JD, Chattergoon M, Muthumani K, Kudchodkar S, Kim J, Bagarazzi M, Pavlakis G, Sekaly R, Weiner DB. Next generation DNA vaccines for HIV-1. Journal of Liposome Research. 12: 137-42. PMID 12604047 DOI: 10.1081/LPR-120004786  0.88
2002 Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, Krammer PH, Sekaly RP, Badley AD. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation Cell Death and Differentiation. 9: 1172-1184. PMID 12404116 DOI: 10.1038/sj.cdd.4401094  0.88
2001 Champagne P, Dumont AR, Sékaly RP. Learning to remember: generation and maintenance of T-cell memory. Dna and Cell Biology. 20: 745-60. PMID 11879568 DOI: 10.1089/104454901753438561  0.4
2001 Sharif-Askari E, Alam A, Rhéaume E, Beresford PJ, Scotto C, Sharma K, Lee D, DeWolf WE, Nuttall ME, Lieberman J, Sékaly RP. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. The Embo Journal. 20: 3101-13. PMID 11406587 DOI: 10.1093/emboj/20.12.3101  0.88
2001 Cameron TO, Cochran JR, Yassine-Diab B, Sékaly RP, Stern LJ. Cutting edge: detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state. Journal of Immunology (Baltimore, Md. : 1950). 166: 741-5. PMID 11145645  0.88
2000 Brenner B, Wainberg MA, Salomon H, Rouleau D, Dascal A, Spira B, Sekaly RP, Conway B, Routy JP. Resistance to antiretroviral drugs in patients with primary HIV-1 infection International Journal of Antimicrobial Agents. 16: 429-434. PMID 11118853 DOI: 10.1016/S0924-8579(00)00270-3  0.88
2000 Routy JP, Vanhems P, Rouleau D, Tsoukas C, Lefèbvre E, Côté P, LeBlanc R, Conway B, Alary M, Bruneau J, Sekaly RP. Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use Journal of Acquired Immune Deficiency Syndromes. 24: 425-432. PMID 11035609  0.88
2000 Gratton S, Haughn L, Sekaly RP, Julius M. The extracellular domain of CD4 regulates the initiation of T cell activation Molecular Immunology. 37: 213-219. PMID 10930628 DOI: 10.1016/S0161-5890(00)00046-8  0.88
2000 Denis F, Shoukry NH, Delcourt M, Thibodeau J, Labrecque N, McGrath H, Munzer JS, Seidah NG, Sékaly RP. Alternative proteolytic processing of mouse mammary tumor virus superantigens. Journal of Virology. 74: 3067-73. PMID 10708421 DOI: 10.1128/JVI.74.7.3067-3073.2000  0.88
2000 Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D, Routy JP. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study. Aids (London, England). 14: F17-23. PMID 10708278 DOI: 10.1097/00002030-200001280-00003  0.88
2000 Hassan-Zahraee M, Ladiwala U, Lavoie PM, McCrea E, Sekaly RP, Owens T, Antel JP. Superantigen presenting capacity of human astrocytes Journal of Neuroimmunology. 102: 131-136. PMID 10636481 DOI: 10.1016/S0165-5728(99)00174-5  0.88
2000 Soudeyns H, Champagne P, Holloway CL, Silvestri GU, Ringuette N, Samson J, Lapointe N, Sékaly RP. Transient T cell receptor β-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: Characterization of expanded cell populations by T cell receptor phenotyping Journal of Infectious Diseases. 181: 107-120. PMID 10608757 DOI: 10.1086/315181  0.88
1999 Poulin JF, Sékaly RP. Function of the thymus in HIV-infected adults. Jama. 282: 219. PMID 10422975 DOI: 10.1001/jama.282.3.219  0.88
1999 Lavoie PM, Thibodeau J, Erard F, Sékaly RP. Understanding the mechanism of action of bacterial superantigens from a decade of research Immunological Reviews. 168: 257-269. PMID 10399079 DOI: 10.1111/j.1600-065X.1999.tb01297.x  0.88
1999 Andersen PS, Lavoie PM, Sékaly RP, Churchill H, Kranz DM, Schlievert PM, Karjalainen K, Mariuzza RA. Role of the T cell receptor α chain in stabilizing TCR-superantigen- MHC class II complexes Immunity. 10: 473-483. PMID 10229190 DOI: 10.1016/S1074-7613(00)80047-3  0.88
1998 Gratton S, Julius M, Sekaly RP. lck-independent inhibition of T cell antigen response by the HIV gp120 Journal of Immunology. 161: 3551-3556. PMID 9759876  0.88
1998 Gayama S, Doyon L, Vaupel B, Sekaly RP, Kanagawa O. Induction of endogenous mammary tumor virus in lymphocytes infected with murine acquired immunodeficiency syndrome virus Cellular Immunology. 187: 124-130. PMID 9732700 DOI: 10.1006/cimm.1998.1326  0.88
1998 Conway B, Routy JP, Sekaly RP. Combination therapy for HIV: Towards long term control of disease progression Expert Opinion On Investigational Drugs. 7: 941-961. DOI: 10.1517/13543784.7.6.941  0.88
1997 Rhéaume E, Cohen LY, Uhlmann F, Lazure C, Alam A, Hurwitz J, Sékaly RP, Denis F. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis. The Embo Journal. 16: 6346-54. PMID 9351817 DOI: 10.1093/emboj/16.21.6346  0.88
1997 Shoukry NH, Lavoie PM, Thibodeau J, D'Souza S, Sekaly RP. MHC class II-dependent peptide antigen versus superantigen presentation to T cells Human Immunology. 54: 194-201. PMID 9297538 DOI: 10.1016/S0198-8859(97)00074-8  0.88
1997 Lavoie PM, Thibodeau J, Cloutier I, Busch R, Sekaly RP. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA- DM Proceedings of the National Academy of Sciences of the United States of America. 94: 6892-6897. PMID 9192662 DOI: 10.1073/pnas.94.13.6892  0.88
1997 Delcourt M, Thibodeau J, Denis F, Sekaly RP. Paracrine transfer of mouse mammary tumor virus superantigen. The Journal of Experimental Medicine. 185: 471-80. PMID 9053447 DOI: 10.1084/jem.185.3.471  0.88
1997 De Alba YB, Marche PN, Cazenave PA, Cloutier I, Sekaly RP, Thibodeau J. Vα domain modulates the multiple topologies of mouse T cell receptor vβ20/staphylococcal enterotoxins A and E complexes European Journal of Immunology. 27: 92-99. PMID 9022003 DOI: 10.1002/eji.1830270114  0.88
1997 Huang B, Yachou A, Fleury S, Hendrickson WA, Sekaly RP. Analysis of the contact sites on the CD4 molecule with class II MHC molecule: co-ligand versus co-receptor function. Journal of Immunology (Baltimore, Md. : 1950). 158: 216-25. PMID 8977193  0.88
1996 Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen Journal of Experimental Medicine. 184: 971-980. PMID 9064357  0.88
1996 Liao L, Marinescu A, Molano A, Ciurli C, Sekaly RP, Fraser JD, Popowicz A, Posnett DN. TCR binding differs for a bacterial superantigen (SEE) and a viral superantigen (Mtv-9) Journal of Experimental Medicine. 184: 1471-1482. PMID 8879218 DOI: 10.1084/jem.184.4.1471  0.88
1996 Silvestri G, Soudeyns H, Samson J, Denis F, Lapointe N, Sekaly RP. T-cell receptor Vβ-specific expansions in children from HIV-infected mothers [4] Aids. 10: 549-551. PMID 8724051 DOI: 10.1097/00002030-199605000-00018  0.88
1996 Duplay P, Alcover A, Fargeas C, Sékaly RP, Branton PE. An activated epidermal growth factor receptor/Lck chimera restores early T cell receptor-mediated calcium response in a CD45-deficient T cell line Journal of Biological Chemistry. 271: 17896-17902. PMID 8663450 DOI: 10.1074/jbc.271.30.17896  0.88
1996 Arthos J, Alizadehfar R, Dandache S, Ringuette N, Silvestri G, Soudeyns H, Sekaly RP. The TcR β-chain repertoire - Evolution and polymorphisms in nonhuman primates Immunologist. 4: 109-110+112.  0.88
1995 Yao XJ, Friborg J, Checroune F, Gratton S, Boisvert F, Sékaly RP, Cohen EA. Degradation of CD4 Induced by Human Immunodeficiency Virus Type 1 Vpu Protein: A Predicted Alpha-Helix Structure in the Proximal Cytoplasmic Region of CD4 Contributes to Vpu Sensitivity Virology. 209: 615-623. PMID 7778293 DOI: 10.1006/viro.1995.1293  0.88
1995 Fleury S, Thibodeau J, Croteau G, Labrecque N, Aronson HE, Cantin C, Long EO, Sékaly RP. HLA-DR polymorphism affects the interaction with CD4 Journal of Experimental Medicine. 182: 733-741. PMID 7650480 DOI: 10.1084/jem.182.3.733  0.88
1995 Mehindate K, Thibodeau J, Dohlsten M, Kalland T, Sékaly RP, Mourad W. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression Journal of Experimental Medicine. 182: 1573-1577. PMID 7595227 DOI: 10.1084/jem.182.5.1573  0.88
1994 Thibodeau J, Labrecque N, Denis F, Huber BT, Sékaly RP. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules Journal of Experimental Medicine. 179: 1029-1034. PMID 8113671 DOI: 10.1084/jem.179.3.1029  0.88
1994 Thibodeau J, Cloutier I, Lavoie PM, Labrecque N, Mourad W, Jardetzky T, Sékaly RP. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding Science. 266: 1874-1878. PMID 7997881  0.88
1994 Ziegler O, Cantin C, Germain L, Dupuis M, Sekaly RP, Drouin P, Chiasson JL. Insulin binding to human cultured lymphocytes measured by flow cytometry using three ligands Cytometry. 16: 339-345. PMID 7988295 DOI: 10.1002/cyto.990160408  0.88
1994 Labrecque N, Thibodeau J, Mourad W, Sékaly RP. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens Journal of Experimental Medicine. 180: 1921-1929. PMID 7964467 DOI: 10.1084/jem.180.5.1921  0.88
1994 Rebai N, Pantaleo G, Demarest JF, Ciurli C, Soudeyns H, Adelsberger JW, Vaccarezza M, Walker RE, Sekaly RP, Fauci AS. Analysis of the T-cell receptor β-chain variable-region (Vβ) repertoire in monozygotic twins discordant for human immunodeficiency virus: Evidence for perturbations of specific Vβ segments in CD4+ T cells of the virus-positive twins Proceedings of the National Academy of Sciences of the United States of America. 91: 1529-1533. PMID 7906416 DOI: 10.1073/pnas.91.4.1529  0.88
1993 Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, Cashman NR. Amyloid Precursor Protein in Peripheral Mononuclear Cells Is Up-Regulated with Cell Activation Journal of Immunology. 150: 5566-5575. PMID 8515076  0.88
1993 Labrecque N, Thibodeau J, Sékaly RP. Interactions between staphylococcal superantigens and MHC class II molecules Seminars in Immunology. 5: 23-32. PMID 8467091 DOI: 10.1006/smim.1993.1004  0.88
1993 Subramanyam M, McLellan B, Labrecque N, Sekaly RP, Huber BT. Presentation of the Mls-1 Superantigen by Human HLA Class II Molecules to Murine T Cells Journal of Immunology. 151: 2538-2545. PMID 8395548  0.88
1993 Labrecque N, McGrath H, Subramanyam M, Huber BT, Sekaly RP. Human T cells respond to mouse mammary tumor virus-encoded superantigen: Vβ restriction and conserved evolutionary features Journal of Experimental Medicine. 177: 1735-1743. PMID 8388432  0.88
1993 Labrecque N, Thibodeau J, Sékaly RP. T-cell receptor recognition of superantigens : another view Research in Immunology. 144: 175-180. PMID 7694342 DOI: 10.1016/0923-2494(93)80113-D  0.88
1993 Hivroz C, Mazerolles F, Soula M, Fagard R, Graton S, Meloche S, Sekaly RP, Fischer A. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes European Journal of Immunology. 23: 600-607. PMID 7680610  0.88
1993 Thibodeau J, Croteau G, Labrecque N, Sekaly RP. Bacterial superantigens: Pathogenic agents or therapeutic tools Medecine/Sciences. 9: 605-613.  0.88
1992 Hadrava V, Tremblay J, Sekaly RP, Hamet P. Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into the S phase of the cell cycle Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 70: 599-604. PMID 1449726  0.88
1992 Hendrickson WA, Kwong PD, Leahy DJ, Ryu SE, Yamaguchi H, Fleury S, Sékaly RP. Structural aspects of CD4 and CD8 involvement in the cellular immune response. Cold Spring Harbor Symposia On Quantitative Biology. 57: 549-56. PMID 1339692  0.88
1992 Paquette Y, Doyon L, Laperrière A, Hanna Z, Ball J, Sekaly RP, Jolicoeur P. A viral long terminal repeat expressed in CD4+CD8+ precursors is downregulated in mature peripheral CD4-CD8+ or CD4+CD8- T cells. Molecular and Cellular Biology. 12: 3522-30. PMID 1321339  0.88
1992 Fleury SG, Zerbib AC, Lamarre D, Meloche S, Sekaly RP. The CD4 molecule a receptor with multiple interactions Medecine/Sciences. 8: 26-33.  0.88
1991 Ansotegui IJ, Chow SC, Jeddi-Tehrani M, Meloche S, Pawson A, Sekaly RP, Mak TW, Wigzell H. Characterization of a monoclonal antibody directed against the phosphotyrosine kinase p56(lck), in human T cells Scandinavian Journal of Immunology. 33: 375-380. PMID 2017663 DOI: 10.1111/j.1365-3083.1991.tb01784.x  0.88
1991 Sekaly RP, Croteau G, Bowman M, Scholl P, Burakoff S, Geha RS. The CD4 molecule is not always required for the T cell response to bacterial enterotoxins Journal of Experimental Medicine. 173: 367-371. PMID 1988539  0.88
1991 Herman A, Labrecque N, Thibodeau J, Marrack P, Kappler JW, Sekaly RP. Identification of the staphylococcal enterotoxin A superantigen binding site in the β1 domain of the human histocompatibility antigen HLA-DR Proceedings of the National Academy of Sciences of the United States of America. 88: 9954-9958. PMID 1946464  0.88
1991 Fleury S, Lamarre D, Meloche S, Ryu SE, Cantin C, Hendrickson WA, Sekaly RP. Mutational analysis of the interaction between CD4 and class II MHC: Class II antigens contact CD4 on a surface opposite the gp120-binding site Cell. 66: 1037-1049. PMID 1889086 DOI: 10.1016/0092-8674(91)90447-7  0.88
1991 Carrel S, Salvi S, Rafti F, Favrot M, Rapin C, Sekaly RP. Direct involvement of CD7 (gp40) in activation of TcR γ/δ+ T cells European Journal of Immunology. 21: 1195-1200. PMID 1709867  0.88
1991 Biassoni R, Ferrini S, Prigione I, Pelak VS, Sekaly RP, Long EO. Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated αβ+ and γδ+ T cells Scandinavian Journal of Immunology. 33: 247-252. PMID 1707180 DOI: 10.1111/j.1365-3083.1991.tb01769.x  0.88
1991 Carrel S, Salvi S, Gallay P, Rapin C, Sekaly RP. Positive signal transduction via surface CD4 molecules does not need coexpression of the CD3/TcR complex Research in Immunology. 142: 97-108. PMID 1678202 DOI: 10.1016/0923-2494(91)90017-D  0.88
1991 Long EO, Rosen-Bronson S, Karp DR, Malnati M, Sekaly RP, Jaraquemada D. Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells Human Immunology. 31: 229-235. PMID 1655683 DOI: 10.1016/0198-8859(91)90092-N  0.88
1990 Scholl PR, Diez A, Karr R, Sekaly RP, Trowsdale J, Geha RS. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules Journal of Immunology. 144: 226-230. PMID 2404064  0.88
1990 Scholl PR, Sekaly RP, Diez A, Glimcher LH, Geha RS. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules European Journal of Immunology. 20: 1911-1916. PMID 2209697  0.88
1990 Tremblay M, Meloche S, Sekaly RP, Wainberg MA. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in epstein-barr virus-carrying B cells Journal of Experimental Medicine. 171: 1791-1796. PMID 2159052  0.88
1990 Kanagawa O, Nakauchi H, Sekaly RP, Maeda K, Takagaki Y. Expression and function of the tranfected CD8α chain in murine T cell hybridomas International Immunology. 2: 957-964. PMID 2127694 DOI: 10.1093/intimm/2.10.957  0.88
1990 Herman A, Croteau G, Sekaly RP, Kappler J, Marrack P. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells Journal of Experimental Medicine. 172: 709-717. PMID 2117633 DOI: 10.1084/jem.172.3.709  0.88
1989 Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells Journal of Virology. 63: 1756-1762. PMID 2784508  0.88
1989 Lamarre D, Capon DJ, Karp DR, Gregory T, Long EO, Sekaly RP. Class II MHC molecules and the HIV gp120 envelope protein interact with functionally distinct regions of the CD4 molecule Embo Journal. 8: 3271-3277. PMID 2555159  0.88
1989 Lamarre D, Ashkenazi A, Fleury S, Smith DH, Sekaly RP, Capon DJ. The MHC-binding and gp120-binding functions of CD4 are separable. Science (New York, N.Y.). 245: 743-6. PMID 2549633  0.88
1989 Biassoni R, Ferrini S, Sekaly RP, Long EO. Transcription of unrearranged T cell receptor δ genes in CD3- major histocompatibility complex-unrestricted cytotoxic cells European Journal of Immunology. 19: 1973-1976. PMID 2479569  0.88
1989 Carrel S, Lamarre D, Isler P, Rapin C, Fleury S, Salvi S, Sekaly RP, Cerottini JC. A positive signal is transduced via surface CD4 molecules Research in Immunology. 140: 545-561. PMID 2476842 DOI: 10.1016/0923-2494(89)90119-3  0.88
1988 Sekaly RP, Jacobson S, Richert JR, Tonnelle C, McFarland HF, Long EO. Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain Proceedings of the National Academy of Sciences of the United States of America. 85: 1209-1212. PMID 3257576  0.88
1988 Jacobson S, Sekaly RP, Bellini WJ, Johnson CL, McFarland HF, Long EO. Recognition of intracellular measles virus antigens byt HLA class II restricted measles virus-specific cytotoxic T lymphocytes Annals of the New York Academy of Sciences. 540: 352-353. PMID 2905123  0.88
1988 Eckels DD, Sell TW, Long EO, Sekaly RP. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts Human Immunology. 21: 173-181. PMID 2453491 DOI: 10.1016/0198-8859(88)90069-9  0.88
1987 Gay D, Maddon P, Sekaly R, Talle MA, Godfrey M, Long E, Goldstein G, Chess L, Axel R, Kappler J. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 328: 626-9. PMID 3112582 DOI: 10.1038/328626a0  0.88
1987 Ferrini S, Bottino C, Biassoni R, Poggi A, Sekaly RP, Moretta L, Moretta A. Characterization of CD3+, CD4-, CD8- clones expressing the putative T cell receptor γ gene product. Analysis of the activation pathways leading to interleukin 2 production and triggering of the lytic machinery Journal of Experimental Medicine. 166: 277-282. PMID 3110350 DOI: 10.1084/jem.166.1.277  0.88
1986 Sekaly RP, Tonnelle C, Strubin M, Mach B, Long EO. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain Journal of Experimental Medicine. 164: 1490-1504. PMID 2430042 DOI: 10.1084/jem.164.5.1490  0.88
1985 Cillo C, Sekaly RP, Magli MC, Odartchenko N. Early hemopoietic progenitor cells: Direct measurement of cell cycle status Annals of the New York Academy of Sciences. 150-161. PMID 3868317  0.88
1984 Carrel S, Gross N, Heumann D, Sekaly RP, Girardet C, Schmidt-Kessen A, Mach JP. Monoclonal antibody against a "Pan-T-Cell" antigen expressed by thymocytes, peripheral T-lymphocytes and T-cell leukemias Molecular Immunology. 21: 831-840. PMID 6438496 DOI: 10.1016/0161-5890(84)90136-6  0.88
1984 Harris DT, Sekaly RP. Target cell susceptibility to immune lysis and expression of MHC antigens are independent of position in the cell cycle Journal of Immunology. 133: 40-44. PMID 6427344  0.88
1984 Sekaly RP, MacDonald HR, Nabholz M, Smith KA, Cerottini JC. Regulation of the rate of cell cycle progression in quiescent cytolytic T cells by T cell growth factor: Analysis by flow microfluorometry Journal of Cellular Physiology. 121: 159-166. PMID 6332815 DOI: 10.1002/jcp.1041210120  0.88
1983 Sekaly RP, Ceredig R, MacDonald HR. Generation of thymocyte subpopulations in organ culture: Correlated analysis of Lyt-2 phenotype and cell cycle status by flow microfluorometry Journal of Immunology. 131: 1085-1089. PMID 6604087  0.88
1983 Ceredig R, Sekaly RP, Macdonald HR. Differentiation in vitro of Lyt 2+ thymocytes from embryonic Lyt 2- precursors Nature. 303: 248-250. PMID 6601775 DOI: 10.1038/303248a0  0.88
1983 Carrel S, Heumann D, Sekaly RP, Zaech P, Buchegger F, Girardet C. Characterization of a monoclonal antibody (A12) that defines a human acute lymphoblastic leukemia-associated differentiation antigen Hybridoma. 2: 149-160. PMID 6205973  0.88
1982 Conzelmann A, Silva A, Cianfriglia M, Tougne C, Sekaly RP, Nabholz M. Correlated expression of T cell growth factor dependence, sensitivity to Vicia villosa lectin, and cytolytic activity in hybrids between cytolytic T cells and T lymphomas Journal of Experimental Medicine. 156: 1335-1351. PMID 6982303 DOI: 10.1084/jem.156.5.1335  0.88
1982 Sekaly RP, MacDonald HR, Zaech P, Nabholz M. Cell cycle regulation of cloned cytolytic T cells by T cell growth factor: Analysis by flow microfluorometry Journal of Immunology. 129: 1407-1415. PMID 6980934  0.88
1982 Accolla RS, Sekaly RP, McDonald AP, Corte G, Gross N, Carrel S. Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets. European Journal of Immunology. 12: 166-9. PMID 6176457 DOI: 10.1002/eji.1830120212  0.88
1981 Sekaly RP, MacDonald HR, Zaech P, Glasebrook AL, Cerottini JC. Cytolytic T lymphocyte function is independent of growth phase and position in the mitotic cycle Journal of Experimental Medicine. 154: 575-580. PMID 6973610 DOI: 10.1084/jem.154.2.575  0.88
1981 Moretta A, Mingari MC, Haynes BF, Sekaly RP, Moretta L, Fauci AS. Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture Journal of Experimental Medicine. 153: 213-218. PMID 6450261 DOI: 10.1084/jem.153.1.213  0.88
Show low-probability matches.